【24h】

Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast.

机译:在乳腺超声引导下活检时,低估了非典型导管增生。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: The purpose of this study was to determine the rate of underestimation of atypical ductal hyperplasia (ADH) at sonographically guided core biopsy of the breast and to identify the factors involved. MATERIALS AND METHODS: We retrospectively reviewed 3,563 lesions con secutively evaluated with sonographically guided core biopsy between January 2002 and June 2006. Histologic analysis yielded ADH in 60 of the 3,563 lesions (1.7%). The rate of underestimation of ADH was determined by dividing the number of lesions that proved to be carcinoma at surgical excision by 44, the total number of lesions evaluated with excisional biopsy. Clinical, sonographic, and core biopsy features were analyzed to identify factors that affect the rate of underestimation of ADH. RESULTS: The rate of underestimation of ADH was found to be 48% (21 of 44 lesions). Underestimation of ADH was significantly less frequent for lesions evaluated with 11-gauge vacuum-assisted biopsy than for lesions evaluated with 14-gauge automated gun biopsy (22% [four of 18 lesions] vs 65% [17 of 26 lesions], p = 0.012). The other clinical, sonographic, and biopsy features examined did not affect the rate of underestimation of ADH. CONCLUSION: For sonographically guided core biopsy of the breast, the rate of underestimation of ADH was 48%. This rate was lower for lesions evaluated with 11-gauge vacuum-assisted biopsy (22%) than for those evaluated with 14-gauge automated gun biopsy (65%). This finding was particularly true of smaller lesions (< or = 2.0 cm) and for lesions of the mass-only type.
机译:目的:本研究的目的是确定在超声引导下的乳腺穿刺活检中对非典型导管增生(ADH)的低估率,并确定相关因素。材料与方法:我们回顾性回顾了2002年1月至2006年6月间经超声引导的核心穿刺活检连续评估的3,563个病变。组织学分析显示,在3,563个病变中有60个出现了ADH(1.7%)。通过将经手术切除证实为癌的病变数除以切除活检评估的病变总数,可以确定ADH的低估率。临床,超声检查和核心活检特征进行了分析,以确定影响ADH的低估率的因素。结果:发现ADH的低估率为48%(44个病灶中的21个)。通过11号真空辅助活检评估的病变中,ADH的低估发生率明显低于采用14号自动枪活检评估的病变(22%[18个病变中的四个]与65%[26个病变中的17个],p = 0.012)。检查的其他临床,超声检查和活检特征均未影响对ADH的低估率。结论:对于超声引导下的乳房核心活检,ADH的低估率为48%。对于使用11号真空辅助活检进行评估的病变(22%),其发生率要低于采用14号自动枪活检进行评估的病变(65%)。对于较小的病变(≤2.0 cm)和仅肿块型病变,这一发现尤其如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号